Retrospective studies show elevated risks, especially for glomerular or proteinuric kidney disease, but absolute risk remains ...
A meta-analysis of relevant research shows that treatment with a serotonin reuptake inhibitor (SSRI) is associated with an increased risk for brain hemorrhage but that the absolute risk is low.